nodes	percent_of_prediction	percent_of_DWPC	metapath
Nateglinide—type 2 diabetes mellitus—atherosclerosis	0.436	1	CtDrD
Nateglinide—PPARG—atherosclerosis	0.128	0.727	CbGaD
Nateglinide—SLC16A1—Niacin—atherosclerosis	0.0664	0.229	CbGbCtD
Nateglinide—SLC16A1—Pravastatin—atherosclerosis	0.0514	0.177	CbGbCtD
Nateglinide—ALB—atherosclerosis	0.0481	0.273	CbGaD
Nateglinide—ABCC4—Rosuvastatin—atherosclerosis	0.0271	0.0934	CbGbCtD
Nateglinide—SLC22A6—Pravastatin—atherosclerosis	0.0107	0.037	CbGbCtD
Nateglinide—ALB—Rosuvastatin—atherosclerosis	0.0101	0.0346	CbGbCtD
Nateglinide—CYP3A7—Simvastatin—atherosclerosis	0.01	0.0345	CbGbCtD
Nateglinide—CYP3A7-CYP3A51P—Simvastatin—atherosclerosis	0.01	0.0345	CbGbCtD
Nateglinide—CYP3A7—Lovastatin—atherosclerosis	0.0098	0.0338	CbGbCtD
Nateglinide—CYP3A7-CYP3A51P—Lovastatin—atherosclerosis	0.0098	0.0338	CbGbCtD
Nateglinide—CYP3A5—Rosuvastatin—atherosclerosis	0.00808	0.0278	CbGbCtD
Nateglinide—CYP3A5—Simvastatin—atherosclerosis	0.00751	0.0259	CbGbCtD
Nateglinide—CYP3A5—Lovastatin—atherosclerosis	0.00735	0.0253	CbGbCtD
Nateglinide—CYP3A5—Pravastatin—atherosclerosis	0.00735	0.0253	CbGbCtD
Nateglinide—CYP2D6—Niacin—atherosclerosis	0.00583	0.0201	CbGbCtD
Nateglinide—CYP2C9—Rosuvastatin—atherosclerosis	0.00542	0.0187	CbGbCtD
Nateglinide—CYP2C9—Simvastatin—atherosclerosis	0.00504	0.0174	CbGbCtD
Nateglinide—CYP2C9—Lovastatin—atherosclerosis	0.00493	0.017	CbGbCtD
Nateglinide—CYP2C9—Pravastatin—atherosclerosis	0.00493	0.017	CbGbCtD
Nateglinide—CYP2D6—Simvastatin—atherosclerosis	0.00461	0.0159	CbGbCtD
Nateglinide—CYP2D6—Pravastatin—atherosclerosis	0.00451	0.0155	CbGbCtD
Nateglinide—CYP2D6—Lovastatin—atherosclerosis	0.00451	0.0155	CbGbCtD
Nateglinide—CYP3A4—Rosuvastatin—atherosclerosis	0.00315	0.0109	CbGbCtD
Nateglinide—CYP3A4—Ezetimibe—atherosclerosis	0.00315	0.0109	CbGbCtD
Nateglinide—CYP3A4—Simvastatin—atherosclerosis	0.00293	0.0101	CbGbCtD
Nateglinide—CYP3A4—Lovastatin—atherosclerosis	0.00287	0.00988	CbGbCtD
Nateglinide—CYP3A4—Pravastatin—atherosclerosis	0.00287	0.00988	CbGbCtD
Nateglinide—ABCC8—penis—atherosclerosis	0.00194	0.152	CbGeAlD
Nateglinide—Trauma—Pravastatin—atherosclerosis	0.00128	0.0342	CcSEcCtD
Nateglinide—PPARG—leg—atherosclerosis	0.00125	0.098	CbGeAlD
Nateglinide—PPARG—hindlimb—atherosclerosis	0.00112	0.0875	CbGeAlD
Nateglinide—Gastrointestinal symptom NOS—Niacin—atherosclerosis	0.00105	0.0281	CcSEcCtD
Nateglinide—PPARG—appendage—atherosclerosis	0.00096	0.0751	CbGeAlD
Nateglinide—Hepatic enzyme increased—Rosuvastatin—atherosclerosis	0.0009	0.024	CcSEcCtD
Nateglinide—PPARG—artery—atherosclerosis	0.000686	0.0536	CbGeAlD
Nateglinide—Injury—Rosuvastatin—atherosclerosis	0.000672	0.018	CcSEcCtD
Nateglinide—PPARG—endothelium—atherosclerosis	0.000579	0.0453	CbGeAlD
Nateglinide—Injury—Lovastatin—atherosclerosis	0.00057	0.0152	CcSEcCtD
Nateglinide—Urine output increased—Niacin—atherosclerosis	0.00056	0.015	CcSEcCtD
Nateglinide—PPARG—blood vessel—atherosclerosis	0.000534	0.0418	CbGeAlD
Nateglinide—Influenza—Rosuvastatin—atherosclerosis	0.000534	0.0143	CcSEcCtD
Nateglinide—Aspartame—TRPV1—atherosclerosis	0.000527	0.28	CrCbGaD
Nateglinide—Bronchitis—Rosuvastatin—atherosclerosis	0.000514	0.0137	CcSEcCtD
Nateglinide—Polyuria—Niacin—atherosclerosis	0.000512	0.0137	CcSEcCtD
Nateglinide—Injury—Pravastatin—atherosclerosis	0.000482	0.0129	CcSEcCtD
Nateglinide—Neuropathy peripheral—Rosuvastatin—atherosclerosis	0.000467	0.0125	CcSEcCtD
Nateglinide—Jaundice—Rosuvastatin—atherosclerosis	0.000464	0.0124	CcSEcCtD
Nateglinide—Influenza—Lovastatin—atherosclerosis	0.000453	0.0121	CcSEcCtD
Nateglinide—Hepatobiliary disease—Rosuvastatin—atherosclerosis	0.00045	0.012	CcSEcCtD
Nateglinide—Influenza—Ezetimibe—atherosclerosis	0.000444	0.0119	CcSEcCtD
Nateglinide—Upper respiratory tract infection—Ezetimibe—atherosclerosis	0.000413	0.011	CcSEcCtD
Nateglinide—Bronchitis—Simvastatin—atherosclerosis	0.000407	0.0109	CcSEcCtD
Nateglinide—Neuropathy peripheral—Lovastatin—atherosclerosis	0.000396	0.0106	CcSEcCtD
Nateglinide—Upper respiratory tract infection—Simvastatin—atherosclerosis	0.000393	0.0105	CcSEcCtD
Nateglinide—Influenza—Niacin—atherosclerosis	0.000389	0.0104	CcSEcCtD
Nateglinide—Neuropathy peripheral—Ezetimibe—atherosclerosis	0.000388	0.0104	CcSEcCtD
Nateglinide—Jaundice—Ezetimibe—atherosclerosis	0.000386	0.0103	CcSEcCtD
Nateglinide—Influenza—Pravastatin—atherosclerosis	0.000383	0.0102	CcSEcCtD
Nateglinide—Hepatobiliary disease—Ezetimibe—atherosclerosis	0.000374	0.01	CcSEcCtD
Nateglinide—Bronchitis—Niacin—atherosclerosis	0.000374	0.00999	CcSEcCtD
Nateglinide—Sweating increased—Pravastatin—atherosclerosis	0.000373	0.00996	CcSEcCtD
Nateglinide—Neuropathy peripheral—Simvastatin—atherosclerosis	0.00037	0.00988	CcSEcCtD
Nateglinide—Jaundice—Simvastatin—atherosclerosis	0.000368	0.00983	CcSEcCtD
Nateglinide—PTGS1—artery—atherosclerosis	0.000367	0.0287	CbGeAlD
Nateglinide—Upper respiratory tract infection—Pravastatin—atherosclerosis	0.000356	0.0095	CcSEcCtD
Nateglinide—Oedema peripheral—Ezetimibe—atherosclerosis	0.00035	0.00935	CcSEcCtD
Nateglinide—Erythema multiforme—Lovastatin—atherosclerosis	0.000343	0.00915	CcSEcCtD
Nateglinide—KCNJ11—cardiovascular system—atherosclerosis	0.000339	0.0265	CbGeAlD
Nateglinide—Jaundice—Niacin—atherosclerosis	0.000338	0.00902	CcSEcCtD
Nateglinide—Erythema multiforme—Ezetimibe—atherosclerosis	0.000336	0.00897	CcSEcCtD
Nateglinide—Neuropathy peripheral—Pravastatin—atherosclerosis	0.000335	0.00894	CcSEcCtD
Nateglinide—Jaundice—Pravastatin—atherosclerosis	0.000333	0.00889	CcSEcCtD
Nateglinide—Sweating—Niacin—atherosclerosis	0.000332	0.00888	CcSEcCtD
Nateglinide—Cough—Rosuvastatin—atherosclerosis	0.000325	0.00867	CcSEcCtD
Nateglinide—Immune system disorder—Ezetimibe—atherosclerosis	0.000321	0.00857	CcSEcCtD
Nateglinide—Erythema multiforme—Simvastatin—atherosclerosis	0.00032	0.00856	CcSEcCtD
Nateglinide—ABCC8—cardiovascular system—atherosclerosis	0.000312	0.0244	CbGeAlD
Nateglinide—PTGS1—endothelium—atherosclerosis	0.00031	0.0242	CbGeAlD
Nateglinide—Malnutrition—Ezetimibe—atherosclerosis	0.000309	0.00826	CcSEcCtD
Nateglinide—Oedema peripheral—Niacin—atherosclerosis	0.000307	0.00819	CcSEcCtD
Nateglinide—Back pain—Lovastatin—atherosclerosis	0.000305	0.00815	CcSEcCtD
Nateglinide—UGT1A9—liver—atherosclerosis	0.0003	0.0234	CbGeAlD
Nateglinide—Back pain—Ezetimibe—atherosclerosis	0.000299	0.00799	CcSEcCtD
Nateglinide—Tremor—Lovastatin—atherosclerosis	0.000295	0.00789	CcSEcCtD
Nateglinide—Erythema multiforme—Pravastatin—atherosclerosis	0.00029	0.00774	CcSEcCtD
Nateglinide—PTGS1—blood vessel—atherosclerosis	0.000286	0.0223	CbGeAlD
Nateglinide—SLC16A1—cardiovascular system—atherosclerosis	0.000284	0.0222	CbGeAlD
Nateglinide—Tremor—Simvastatin—atherosclerosis	0.000276	0.00738	CcSEcCtD
Nateglinide—PPARG—connective tissue—atherosclerosis	0.000274	0.0214	CbGeAlD
Nateglinide—Palpitations—Ezetimibe—atherosclerosis	0.000273	0.0073	CcSEcCtD
Nateglinide—Malnutrition—Niacin—atherosclerosis	0.000271	0.00724	CcSEcCtD
Nateglinide—Cough—Ezetimibe—atherosclerosis	0.00027	0.00721	CcSEcCtD
Nateglinide—Dyspepsia—Rosuvastatin—atherosclerosis	0.000267	0.00714	CcSEcCtD
Nateglinide—SLC16A1—adipose tissue—atherosclerosis	0.000251	0.0196	CbGeAlD
Nateglinide—Tremor—Pravastatin—atherosclerosis	0.00025	0.00667	CcSEcCtD
Nateglinide—CYP3A7—liver—atherosclerosis	0.000249	0.0195	CbGeAlD
Nateglinide—Gastrointestinal pain—Rosuvastatin—atherosclerosis	0.000248	0.00663	CcSEcCtD
Nateglinide—Urticaria—Rosuvastatin—atherosclerosis	0.000241	0.00645	CcSEcCtD
Nateglinide—Abdominal pain—Rosuvastatin—atherosclerosis	0.00024	0.00641	CcSEcCtD
Nateglinide—Palpitations—Niacin—atherosclerosis	0.000239	0.00639	CcSEcCtD
Nateglinide—PPARG—cardiovascular system—atherosclerosis	0.000238	0.0186	CbGeAlD
Nateglinide—Cough—Niacin—atherosclerosis	0.000236	0.00631	CcSEcCtD
Nateglinide—Cough—Pravastatin—atherosclerosis	0.000233	0.00622	CcSEcCtD
Nateglinide—Dyspepsia—Lovastatin—atherosclerosis	0.000227	0.00605	CcSEcCtD
Nateglinide—Hypersensitivity—Rosuvastatin—atherosclerosis	0.000224	0.00598	CcSEcCtD
Nateglinide—Dyspepsia—Ezetimibe—atherosclerosis	0.000222	0.00594	CcSEcCtD
Nateglinide—Fatigue—Lovastatin—atherosclerosis	0.000222	0.00593	CcSEcCtD
Nateglinide—Spirapril—ACE—atherosclerosis	0.000221	0.118	CrCbGaD
Nateglinide—Gastrointestinal disorder—Ezetimibe—atherosclerosis	0.000218	0.00582	CcSEcCtD
Nateglinide—Asthenia—Rosuvastatin—atherosclerosis	0.000218	0.00582	CcSEcCtD
Nateglinide—Fatigue—Ezetimibe—atherosclerosis	0.000218	0.00581	CcSEcCtD
Nateglinide—Pruritus—Rosuvastatin—atherosclerosis	0.000215	0.00574	CcSEcCtD
Nateglinide—Hyperhidrosis—Niacin—atherosclerosis	0.000214	0.00571	CcSEcCtD
Nateglinide—CYP3A7-CYP3A51P—liver—atherosclerosis	0.000212	0.0166	CbGeAlD
Nateglinide—Dyspepsia—Simvastatin—atherosclerosis	0.000212	0.00566	CcSEcCtD
Nateglinide—Mitiglinide—PPARG—atherosclerosis	0.000211	0.112	CrCbGaD
Nateglinide—Gastrointestinal pain—Lovastatin—atherosclerosis	0.00021	0.00562	CcSEcCtD
Nateglinide—Hyperhidrosis—Pravastatin—atherosclerosis	0.00021	0.00562	CcSEcCtD
Nateglinide—PPARG—adipose tissue—atherosclerosis	0.00021	0.0164	CbGeAlD
Nateglinide—Gastrointestinal disorder—Simvastatin—atherosclerosis	0.000208	0.00555	CcSEcCtD
Nateglinide—Diarrhoea—Rosuvastatin—atherosclerosis	0.000208	0.00555	CcSEcCtD
Nateglinide—Fatigue—Simvastatin—atherosclerosis	0.000208	0.00554	CcSEcCtD
Nateglinide—Gastrointestinal pain—Ezetimibe—atherosclerosis	0.000206	0.00551	CcSEcCtD
Nateglinide—Urticaria—Lovastatin—atherosclerosis	0.000204	0.00546	CcSEcCtD
Nateglinide—Abdominal pain—Lovastatin—atherosclerosis	0.000203	0.00544	CcSEcCtD
Nateglinide—Dizziness—Rosuvastatin—atherosclerosis	0.000201	0.00536	CcSEcCtD
Nateglinide—Urticaria—Ezetimibe—atherosclerosis	0.000201	0.00536	CcSEcCtD
Nateglinide—Abdominal pain—Ezetimibe—atherosclerosis	0.0002	0.00533	CcSEcCtD
Nateglinide—Lisinopril—ACE—atherosclerosis	0.000197	0.105	CrCbGaD
Nateglinide—Cilazapril—ACE—atherosclerosis	0.000197	0.105	CrCbGaD
Nateglinide—Gastrointestinal pain—Simvastatin—atherosclerosis	0.000197	0.00526	CcSEcCtD
Nateglinide—Dyspepsia—Niacin—atherosclerosis	0.000195	0.0052	CcSEcCtD
Nateglinide—Dyspepsia—Pravastatin—atherosclerosis	0.000192	0.00512	CcSEcCtD
Nateglinide—Rash—Rosuvastatin—atherosclerosis	0.000191	0.00512	CcSEcCtD
Nateglinide—Dermatitis—Rosuvastatin—atherosclerosis	0.000191	0.00511	CcSEcCtD
Nateglinide—Urticaria—Simvastatin—atherosclerosis	0.000191	0.00511	CcSEcCtD
Nateglinide—ABCC4—adipose tissue—atherosclerosis	0.000191	0.0149	CbGeAlD
Nateglinide—Gastrointestinal disorder—Niacin—atherosclerosis	0.000191	0.0051	CcSEcCtD
Nateglinide—Ramipril—ACE—atherosclerosis	0.000191	0.102	CrCbGaD
Nateglinide—Trandolapril—ACE—atherosclerosis	0.000191	0.102	CrCbGaD
Nateglinide—Abdominal pain—Simvastatin—atherosclerosis	0.00019	0.00508	CcSEcCtD
Nateglinide—Hypersensitivity—Lovastatin—atherosclerosis	0.00019	0.00507	CcSEcCtD
Nateglinide—Fatigue—Pravastatin—atherosclerosis	0.000188	0.00501	CcSEcCtD
Nateglinide—Hypersensitivity—Ezetimibe—atherosclerosis	0.000186	0.00497	CcSEcCtD
Nateglinide—Asthenia—Lovastatin—atherosclerosis	0.000185	0.00493	CcSEcCtD
Nateglinide—SLC15A1—liver—atherosclerosis	0.000185	0.0144	CbGeAlD
Nateglinide—Pruritus—Lovastatin—atherosclerosis	0.000182	0.00486	CcSEcCtD
Nateglinide—Asthenia—Ezetimibe—atherosclerosis	0.000181	0.00484	CcSEcCtD
Nateglinide—Gastrointestinal pain—Niacin—atherosclerosis	0.000181	0.00483	CcSEcCtD
Nateglinide—Nausea—Rosuvastatin—atherosclerosis	0.00018	0.00482	CcSEcCtD
Nateglinide—Pruritus—Ezetimibe—atherosclerosis	0.000179	0.00477	CcSEcCtD
Nateglinide—Gastrointestinal pain—Pravastatin—atherosclerosis	0.000178	0.00475	CcSEcCtD
Nateglinide—Hypersensitivity—Simvastatin—atherosclerosis	0.000177	0.00474	CcSEcCtD
Nateglinide—Diarrhoea—Lovastatin—atherosclerosis	0.000176	0.0047	CcSEcCtD
Nateglinide—SLC16A1—liver—atherosclerosis	0.000176	0.0137	CbGeAlD
Nateglinide—Urticaria—Niacin—atherosclerosis	0.000176	0.00469	CcSEcCtD
Nateglinide—Abdominal pain—Niacin—atherosclerosis	0.000175	0.00467	CcSEcCtD
Nateglinide—Urticaria—Pravastatin—atherosclerosis	0.000173	0.00462	CcSEcCtD
Nateglinide—Asthenia—Simvastatin—atherosclerosis	0.000173	0.00461	CcSEcCtD
Nateglinide—Diarrhoea—Ezetimibe—atherosclerosis	0.000173	0.00461	CcSEcCtD
Nateglinide—Abdominal pain—Pravastatin—atherosclerosis	0.000172	0.0046	CcSEcCtD
Nateglinide—Pruritus—Simvastatin—atherosclerosis	0.00017	0.00455	CcSEcCtD
Nateglinide—Dizziness—Lovastatin—atherosclerosis	0.00017	0.00455	CcSEcCtD
Nateglinide—Dizziness—Ezetimibe—atherosclerosis	0.000167	0.00446	CcSEcCtD
Nateglinide—Diarrhoea—Simvastatin—atherosclerosis	0.000165	0.0044	CcSEcCtD
Nateglinide—Vomiting—Lovastatin—atherosclerosis	0.000164	0.00437	CcSEcCtD
Nateglinide—Hypersensitivity—Niacin—atherosclerosis	0.000163	0.00435	CcSEcCtD
Nateglinide—Rash—Lovastatin—atherosclerosis	0.000162	0.00434	CcSEcCtD
Nateglinide—Dermatitis—Lovastatin—atherosclerosis	0.000162	0.00433	CcSEcCtD
Nateglinide—Vomiting—Ezetimibe—atherosclerosis	0.000161	0.00429	CcSEcCtD
Nateglinide—Hypersensitivity—Pravastatin—atherosclerosis	0.00016	0.00428	CcSEcCtD
Nateglinide—Dizziness—Simvastatin—atherosclerosis	0.000159	0.00425	CcSEcCtD
Nateglinide—Rash—Ezetimibe—atherosclerosis	0.000159	0.00425	CcSEcCtD
Nateglinide—Dermatitis—Ezetimibe—atherosclerosis	0.000159	0.00425	CcSEcCtD
Nateglinide—Asthenia—Niacin—atherosclerosis	0.000159	0.00424	CcSEcCtD
Nateglinide—ORM1—liver—atherosclerosis	0.000158	0.0123	CbGeAlD
Nateglinide—Pruritus—Niacin—atherosclerosis	0.000156	0.00418	CcSEcCtD
Nateglinide—Asthenia—Pravastatin—atherosclerosis	0.000156	0.00417	CcSEcCtD
Nateglinide—Pruritus—Pravastatin—atherosclerosis	0.000154	0.00411	CcSEcCtD
Nateglinide—Vomiting—Simvastatin—atherosclerosis	0.000153	0.00409	CcSEcCtD
Nateglinide—Nausea—Lovastatin—atherosclerosis	0.000153	0.00408	CcSEcCtD
Nateglinide—Rash—Simvastatin—atherosclerosis	0.000152	0.00405	CcSEcCtD
Nateglinide—Dermatitis—Simvastatin—atherosclerosis	0.000152	0.00405	CcSEcCtD
Nateglinide—Diarrhoea—Niacin—atherosclerosis	0.000151	0.00404	CcSEcCtD
Nateglinide—Nausea—Ezetimibe—atherosclerosis	0.00015	0.00401	CcSEcCtD
Nateglinide—Diarrhoea—Pravastatin—atherosclerosis	0.000149	0.00398	CcSEcCtD
Nateglinide—PPARG—liver—atherosclerosis	0.000147	0.0115	CbGeAlD
Nateglinide—PTGS1—connective tissue—atherosclerosis	0.000146	0.0115	CbGeAlD
Nateglinide—Dizziness—Niacin—atherosclerosis	0.000146	0.0039	CcSEcCtD
Nateglinide—Enalapril—ACE—atherosclerosis	0.000145	0.0769	CrCbGaD
Nateglinide—Dizziness—Pravastatin—atherosclerosis	0.000144	0.00384	CcSEcCtD
Nateglinide—Nausea—Simvastatin—atherosclerosis	0.000143	0.00382	CcSEcCtD
Nateglinide—Vomiting—Niacin—atherosclerosis	0.000141	0.00375	CcSEcCtD
Nateglinide—CYP2C9—cardiovascular system—atherosclerosis	0.00014	0.0109	CbGeAlD
Nateglinide—Rash—Niacin—atherosclerosis	0.000139	0.00372	CcSEcCtD
Nateglinide—Dermatitis—Niacin—atherosclerosis	0.000139	0.00372	CcSEcCtD
Nateglinide—Vomiting—Pravastatin—atherosclerosis	0.000138	0.0037	CcSEcCtD
Nateglinide—ALB—liver—atherosclerosis	0.000138	0.0108	CbGeAlD
Nateglinide—Rash—Pravastatin—atherosclerosis	0.000137	0.00367	CcSEcCtD
Nateglinide—Dermatitis—Pravastatin—atherosclerosis	0.000137	0.00366	CcSEcCtD
Nateglinide—ABCC4—liver—atherosclerosis	0.000134	0.0105	CbGeAlD
Nateglinide—Nausea—Niacin—atherosclerosis	0.000131	0.00351	CcSEcCtD
Nateglinide—Nausea—Pravastatin—atherosclerosis	0.000129	0.00345	CcSEcCtD
Nateglinide—PTGS1—cardiovascular system—atherosclerosis	0.000127	0.00997	CbGeAlD
Nateglinide—CYP3A5—adipose tissue—atherosclerosis	0.000125	0.00978	CbGeAlD
Nateglinide—PTGS1—adipose tissue—atherosclerosis	0.000112	0.00879	CbGeAlD
Nateglinide—CYP3A5—liver—atherosclerosis	8.77e-05	0.00686	CbGeAlD
Nateglinide—CYP2C9—liver—atherosclerosis	8.63e-05	0.00675	CbGeAlD
Nateglinide—CYP3A4—liver—atherosclerosis	6.58e-05	0.00515	CbGeAlD
Nateglinide—CYP2D6—liver—atherosclerosis	6.48e-05	0.00507	CbGeAlD
Nateglinide—CYP2C9—Metabolism—PLA2G2A—atherosclerosis	3.58e-06	7.89e-05	CbGpPWpGaD
Nateglinide—CYP2C9—Metabolism—APOA2—atherosclerosis	3.58e-06	7.89e-05	CbGpPWpGaD
Nateglinide—CYP2C9—Metabolism—ALOX15—atherosclerosis	3.58e-06	7.89e-05	CbGpPWpGaD
Nateglinide—CYP2C9—Metabolism—ALOX5AP—atherosclerosis	3.58e-06	7.89e-05	CbGpPWpGaD
Nateglinide—ALB—Transmembrane transport of small molecules—APOA1—atherosclerosis	3.58e-06	7.88e-05	CbGpPWpGaD
Nateglinide—CYP2D6—Metabolism—ABCG5—atherosclerosis	3.57e-06	7.86e-05	CbGpPWpGaD
Nateglinide—CYP3A5—Metabolism—SCARB1—atherosclerosis	3.56e-06	7.83e-05	CbGpPWpGaD
Nateglinide—CYP3A7—Metabolism—HMOX1—atherosclerosis	3.56e-06	7.83e-05	CbGpPWpGaD
Nateglinide—PPARG—Developmental Biology—IL6—atherosclerosis	3.54e-06	7.79e-05	CbGpPWpGaD
Nateglinide—CYP2C9—Metabolism—ABCG5—atherosclerosis	3.54e-06	7.79e-05	CbGpPWpGaD
Nateglinide—CYP2C9—Metabolism of lipids and lipoproteins—CD36—atherosclerosis	3.54e-06	7.78e-05	CbGpPWpGaD
Nateglinide—KCNJ11—Metabolism—PTGS2—atherosclerosis	3.5e-06	7.7e-05	CbGpPWpGaD
Nateglinide—UGT1A9—Metabolism—MTHFR—atherosclerosis	3.48e-06	7.66e-05	CbGpPWpGaD
Nateglinide—ALB—Hemostasis—IGF1—atherosclerosis	3.46e-06	7.61e-05	CbGpPWpGaD
Nateglinide—CYP2D6—Metabolism—LPA—atherosclerosis	3.45e-06	7.59e-05	CbGpPWpGaD
Nateglinide—PTGS1—Metabolism—HMOX1—atherosclerosis	3.45e-06	7.59e-05	CbGpPWpGaD
Nateglinide—SLC16A1—Metabolism—PTGS2—atherosclerosis	3.45e-06	7.59e-05	CbGpPWpGaD
Nateglinide—ALB—Metabolism of lipids and lipoproteins—PIK3CG—atherosclerosis	3.44e-06	7.57e-05	CbGpPWpGaD
Nateglinide—CYP2C9—Metabolism—LPA—atherosclerosis	3.42e-06	7.52e-05	CbGpPWpGaD
Nateglinide—UGT1A9—Metabolism—PPARA—atherosclerosis	3.42e-06	7.52e-05	CbGpPWpGaD
Nateglinide—CYP3A7—Metabolism—APOB—atherosclerosis	3.41e-06	7.5e-05	CbGpPWpGaD
Nateglinide—PPARG—Metabolism—PIK3CG—atherosclerosis	3.41e-06	7.49e-05	CbGpPWpGaD
Nateglinide—CYP3A5—Metabolism—HMGCR—atherosclerosis	3.36e-06	7.4e-05	CbGpPWpGaD
Nateglinide—CYP2D6—Metabolism—BGN—atherosclerosis	3.34e-06	7.35e-05	CbGpPWpGaD
Nateglinide—ALB—Metabolism—NAMPT—atherosclerosis	3.34e-06	7.35e-05	CbGpPWpGaD
Nateglinide—ALB—Metabolism of lipids and lipoproteins—PPARG—atherosclerosis	3.32e-06	7.31e-05	CbGpPWpGaD
Nateglinide—ALB—Metabolism—LIPC—atherosclerosis	3.32e-06	7.3e-05	CbGpPWpGaD
Nateglinide—CYP3A7—Metabolism—GSTM1—atherosclerosis	3.31e-06	7.29e-05	CbGpPWpGaD
Nateglinide—CYP2C9—Metabolism—BGN—atherosclerosis	3.31e-06	7.29e-05	CbGpPWpGaD
Nateglinide—UGT1A9—Metabolism—AGT—atherosclerosis	3.31e-06	7.28e-05	CbGpPWpGaD
Nateglinide—CYP2D6—Metabolism—APOA5—atherosclerosis	3.31e-06	7.28e-05	CbGpPWpGaD
Nateglinide—PTGS1—Metabolism—APOB—atherosclerosis	3.3e-06	7.27e-05	CbGpPWpGaD
Nateglinide—ALB—Metabolism—APOC3—atherosclerosis	3.3e-06	7.26e-05	CbGpPWpGaD
Nateglinide—CYP2C9—Metabolism of lipids and lipoproteins—PPARA—atherosclerosis	3.29e-06	7.24e-05	CbGpPWpGaD
Nateglinide—ALB—Hemostasis—SERPINE1—atherosclerosis	3.29e-06	7.23e-05	CbGpPWpGaD
Nateglinide—CYP2C9—Metabolism—APOA5—atherosclerosis	3.28e-06	7.21e-05	CbGpPWpGaD
Nateglinide—ALB—Metabolism—LDLR—atherosclerosis	3.28e-06	7.21e-05	CbGpPWpGaD
Nateglinide—PPARG—Developmental Biology—AKT1—atherosclerosis	3.27e-06	7.19e-05	CbGpPWpGaD
Nateglinide—CYP3A7—Metabolism—LPL—atherosclerosis	3.25e-06	7.16e-05	CbGpPWpGaD
Nateglinide—UGT1A9—Metabolism—APOE—atherosclerosis	3.24e-06	7.13e-05	CbGpPWpGaD
Nateglinide—PPARG—Metabolism—INS—atherosclerosis	3.22e-06	7.09e-05	CbGpPWpGaD
Nateglinide—PTGS1—Metabolism—GSTM1—atherosclerosis	3.21e-06	7.07e-05	CbGpPWpGaD
Nateglinide—UGT1A9—Metabolism—CAV1—atherosclerosis	3.21e-06	7.07e-05	CbGpPWpGaD
Nateglinide—UGT1A9—Metabolism—APOA1—atherosclerosis	3.21e-06	7.05e-05	CbGpPWpGaD
Nateglinide—ALB—Metabolism—CETP—atherosclerosis	3.2e-06	7.05e-05	CbGpPWpGaD
Nateglinide—ABCC4—Hemostasis—AKT1—atherosclerosis	3.19e-06	7.01e-05	CbGpPWpGaD
Nateglinide—CYP2C9—Metabolism of lipids and lipoproteins—AGT—atherosclerosis	3.18e-06	7.01e-05	CbGpPWpGaD
Nateglinide—CYP2D6—Metabolism—PLA2G1B—atherosclerosis	3.18e-06	7e-05	CbGpPWpGaD
Nateglinide—CYP3A7—Metabolism—GPX1—atherosclerosis	3.17e-06	6.98e-05	CbGpPWpGaD
Nateglinide—CYP2C9—Metabolism—PLA2G1B—atherosclerosis	3.16e-06	6.94e-05	CbGpPWpGaD
Nateglinide—PTGS1—Metabolism—LPL—atherosclerosis	3.15e-06	6.94e-05	CbGpPWpGaD
Nateglinide—ALB—Hemostasis—NOS3—atherosclerosis	3.14e-06	6.9e-05	CbGpPWpGaD
Nateglinide—CYP2C9—Metabolism of lipids and lipoproteins—APOE—atherosclerosis	3.12e-06	6.87e-05	CbGpPWpGaD
Nateglinide—CYP2C9—Metabolism of lipids and lipoproteins—CAV1—atherosclerosis	3.09e-06	6.8e-05	CbGpPWpGaD
Nateglinide—CYP3A7—Metabolism—CD36—atherosclerosis	3.09e-06	6.8e-05	CbGpPWpGaD
Nateglinide—CYP2C9—Metabolism of lipids and lipoproteins—APOA1—atherosclerosis	3.08e-06	6.79e-05	CbGpPWpGaD
Nateglinide—PTGS1—Metabolism—GPX1—atherosclerosis	3.08e-06	6.77e-05	CbGpPWpGaD
Nateglinide—CYP2D6—Metabolism—ALOX5—atherosclerosis	3.07e-06	6.76e-05	CbGpPWpGaD
Nateglinide—ALB—Metabolism—SCARB1—atherosclerosis	3.07e-06	6.75e-05	CbGpPWpGaD
Nateglinide—CYP2C9—Metabolism—ALOX5—atherosclerosis	3.05e-06	6.71e-05	CbGpPWpGaD
Nateglinide—CYP3A5—Metabolism—ABCA1—atherosclerosis	3e-06	6.59e-05	CbGpPWpGaD
Nateglinide—PTGS1—Metabolism—CD36—atherosclerosis	3e-06	6.59e-05	CbGpPWpGaD
Nateglinide—CYP3A4—Metabolism—ABCG1—atherosclerosis	2.98e-06	6.55e-05	CbGpPWpGaD
Nateglinide—PPARG—Metabolism—ALB—atherosclerosis	2.96e-06	6.5e-05	CbGpPWpGaD
Nateglinide—CYP3A7—Metabolism—MTHFR—atherosclerosis	2.93e-06	6.45e-05	CbGpPWpGaD
Nateglinide—UGT1A9—Metabolism—PIK3CG—atherosclerosis	2.93e-06	6.44e-05	CbGpPWpGaD
Nateglinide—ALB—Metabolism—HMGCR—atherosclerosis	2.9e-06	6.37e-05	CbGpPWpGaD
Nateglinide—CYP3A7—Metabolism—PPARA—atherosclerosis	2.87e-06	6.32e-05	CbGpPWpGaD
Nateglinide—PTGS1—Metabolism—MTHFR—atherosclerosis	2.84e-06	6.25e-05	CbGpPWpGaD
Nateglinide—PPARG—Metabolism—NOS3—atherosclerosis	2.83e-06	6.22e-05	CbGpPWpGaD
Nateglinide—UGT1A9—Metabolism—PPARG—atherosclerosis	2.82e-06	6.21e-05	CbGpPWpGaD
Nateglinide—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CG—atherosclerosis	2.82e-06	6.2e-05	CbGpPWpGaD
Nateglinide—CYP3A4—Metabolism—LCAT—atherosclerosis	2.8e-06	6.16e-05	CbGpPWpGaD
Nateglinide—CYP3A4—Metabolism—FABP4—atherosclerosis	2.8e-06	6.16e-05	CbGpPWpGaD
Nateglinide—ALB—Platelet activation, signaling and aggregation—AKT1—atherosclerosis	2.8e-06	6.16e-05	CbGpPWpGaD
Nateglinide—PTGS1—Metabolism—PPARA—atherosclerosis	2.79e-06	6.13e-05	CbGpPWpGaD
Nateglinide—CYP3A7—Metabolism—AGT—atherosclerosis	2.78e-06	6.12e-05	CbGpPWpGaD
Nateglinide—UGT1A9—Metabolism—INS—atherosclerosis	2.77e-06	6.1e-05	CbGpPWpGaD
Nateglinide—CYP2D6—Metabolism—NAMPT—atherosclerosis	2.76e-06	6.07e-05	CbGpPWpGaD
Nateglinide—CYP3A4—Metabolism—APOA4—atherosclerosis	2.75e-06	6.04e-05	CbGpPWpGaD
Nateglinide—CYP2D6—Metabolism—LIPC—atherosclerosis	2.74e-06	6.03e-05	CbGpPWpGaD
Nateglinide—CYP2C9—Metabolism—NAMPT—atherosclerosis	2.73e-06	6.02e-05	CbGpPWpGaD
Nateglinide—CYP3A7—Metabolism—APOE—atherosclerosis	2.73e-06	6e-05	CbGpPWpGaD
Nateglinide—CYP2D6—Metabolism—APOC3—atherosclerosis	2.72e-06	5.99e-05	CbGpPWpGaD
Nateglinide—CYP2C9—Metabolism of lipids and lipoproteins—PPARG—atherosclerosis	2.72e-06	5.98e-05	CbGpPWpGaD
Nateglinide—CYP2C9—Metabolism—LIPC—atherosclerosis	2.72e-06	5.98e-05	CbGpPWpGaD
Nateglinide—CYP2D6—Metabolism—LDLR—atherosclerosis	2.71e-06	5.96e-05	CbGpPWpGaD
Nateglinide—CYP3A7—Metabolism—CAV1—atherosclerosis	2.7e-06	5.95e-05	CbGpPWpGaD
Nateglinide—CYP2C9—Metabolism—APOC3—atherosclerosis	2.7e-06	5.94e-05	CbGpPWpGaD
Nateglinide—CYP3A4—Metabolism—CYP7A1—atherosclerosis	2.7e-06	5.94e-05	CbGpPWpGaD
Nateglinide—PTGS1—Metabolism—AGT—atherosclerosis	2.7e-06	5.94e-05	CbGpPWpGaD
Nateglinide—CYP3A7—Metabolism—APOA1—atherosclerosis	2.7e-06	5.93e-05	CbGpPWpGaD
Nateglinide—CYP2C9—Metabolism—LDLR—atherosclerosis	2.68e-06	5.9e-05	CbGpPWpGaD
Nateglinide—CYP2D6—Metabolism—CETP—atherosclerosis	2.64e-06	5.82e-05	CbGpPWpGaD
Nateglinide—PTGS1—Metabolism—APOE—atherosclerosis	2.64e-06	5.82e-05	CbGpPWpGaD
Nateglinide—CYP2C9—Metabolism—CETP—atherosclerosis	2.62e-06	5.77e-05	CbGpPWpGaD
Nateglinide—PTGS1—Metabolism—CAV1—atherosclerosis	2.62e-06	5.76e-05	CbGpPWpGaD
Nateglinide—PTGS1—Metabolism—APOA1—atherosclerosis	2.61e-06	5.75e-05	CbGpPWpGaD
Nateglinide—ALB—Metabolism of lipids and lipoproteins—PTGS2—atherosclerosis	2.61e-06	5.75e-05	CbGpPWpGaD
Nateglinide—PPARG—Metabolism—PTGS2—atherosclerosis	2.59e-06	5.69e-05	CbGpPWpGaD
Nateglinide—ALB—Metabolism—ABCA1—atherosclerosis	2.58e-06	5.68e-05	CbGpPWpGaD
Nateglinide—CYP3A5—Metabolism—HMOX1—atherosclerosis	2.57e-06	5.66e-05	CbGpPWpGaD
Nateglinide—UGT1A9—Metabolism—ALB—atherosclerosis	2.54e-06	5.59e-05	CbGpPWpGaD
Nateglinide—CYP2D6—Metabolism—SCARB1—atherosclerosis	2.53e-06	5.57e-05	CbGpPWpGaD
Nateglinide—CYP2C9—Metabolism—SCARB1—atherosclerosis	2.51e-06	5.52e-05	CbGpPWpGaD
Nateglinide—CYP3A4—Metabolism—CYP27A1—atherosclerosis	2.49e-06	5.49e-05	CbGpPWpGaD
Nateglinide—PPARG—Gene Expression—MAPK3—atherosclerosis	2.48e-06	5.45e-05	CbGpPWpGaD
Nateglinide—CYP3A5—Metabolism—APOB—atherosclerosis	2.46e-06	5.42e-05	CbGpPWpGaD
Nateglinide—CYP3A7—Metabolism—PIK3CG—atherosclerosis	2.46e-06	5.42e-05	CbGpPWpGaD
Nateglinide—CYP2C9—Metabolism of lipids and lipoproteins—ALB—atherosclerosis	2.44e-06	5.38e-05	CbGpPWpGaD
Nateglinide—UGT1A9—Metabolism—NOS3—atherosclerosis	2.43e-06	5.35e-05	CbGpPWpGaD
Nateglinide—CYP3A5—Metabolism—GSTM1—atherosclerosis	2.4e-06	5.27e-05	CbGpPWpGaD
Nateglinide—CYP2D6—Metabolism—HMGCR—atherosclerosis	2.39e-06	5.26e-05	CbGpPWpGaD
Nateglinide—PTGS1—Metabolism—PIK3CG—atherosclerosis	2.39e-06	5.25e-05	CbGpPWpGaD
Nateglinide—CYP3A7—Metabolism—PPARG—atherosclerosis	2.38e-06	5.23e-05	CbGpPWpGaD
Nateglinide—CYP2C9—Metabolism—HMGCR—atherosclerosis	2.37e-06	5.22e-05	CbGpPWpGaD
Nateglinide—CYP3A4—Metabolism—APOA2—atherosclerosis	2.36e-06	5.2e-05	CbGpPWpGaD
Nateglinide—CYP3A4—Metabolism—PLA2G2A—atherosclerosis	2.36e-06	5.2e-05	CbGpPWpGaD
Nateglinide—CYP3A4—Metabolism—ALOX5AP—atherosclerosis	2.36e-06	5.2e-05	CbGpPWpGaD
Nateglinide—CYP3A4—Metabolism—ALOX15—atherosclerosis	2.36e-06	5.2e-05	CbGpPWpGaD
Nateglinide—CYP3A5—Metabolism—LPL—atherosclerosis	2.35e-06	5.17e-05	CbGpPWpGaD
Nateglinide—CYP3A4—Metabolism—ABCG5—atherosclerosis	2.34e-06	5.14e-05	CbGpPWpGaD
Nateglinide—CYP3A7—Metabolism—INS—atherosclerosis	2.33e-06	5.13e-05	CbGpPWpGaD
Nateglinide—PTGS1—Metabolism—PPARG—atherosclerosis	2.3e-06	5.07e-05	CbGpPWpGaD
Nateglinide—CYP3A5—Metabolism—GPX1—atherosclerosis	2.29e-06	5.05e-05	CbGpPWpGaD
Nateglinide—ALB—Hemostasis—VEGFA—atherosclerosis	2.26e-06	4.97e-05	CbGpPWpGaD
Nateglinide—PTGS1—Metabolism—INS—atherosclerosis	2.26e-06	4.97e-05	CbGpPWpGaD
Nateglinide—CYP3A4—Metabolism—LPA—atherosclerosis	2.26e-06	4.96e-05	CbGpPWpGaD
Nateglinide—CYP3A5—Metabolism—CD36—atherosclerosis	2.23e-06	4.92e-05	CbGpPWpGaD
Nateglinide—UGT1A9—Metabolism—PTGS2—atherosclerosis	2.22e-06	4.89e-05	CbGpPWpGaD
Nateglinide—ALB—Metabolism—HMOX1—atherosclerosis	2.21e-06	4.87e-05	CbGpPWpGaD
Nateglinide—CYP3A4—Metabolism—BGN—atherosclerosis	2.18e-06	4.81e-05	CbGpPWpGaD
Nateglinide—CYP3A4—Metabolism—APOA5—atherosclerosis	2.16e-06	4.76e-05	CbGpPWpGaD
Nateglinide—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—atherosclerosis	2.14e-06	4.7e-05	CbGpPWpGaD
Nateglinide—ALB—Hemostasis—MAPK3—atherosclerosis	2.14e-06	4.7e-05	CbGpPWpGaD
Nateglinide—CYP3A7—Metabolism—ALB—atherosclerosis	2.14e-06	4.7e-05	CbGpPWpGaD
Nateglinide—CYP2D6—Metabolism—ABCA1—atherosclerosis	2.13e-06	4.69e-05	CbGpPWpGaD
Nateglinide—ALB—Metabolism—APOB—atherosclerosis	2.12e-06	4.67e-05	CbGpPWpGaD
Nateglinide—CYP3A5—Metabolism—MTHFR—atherosclerosis	2.12e-06	4.66e-05	CbGpPWpGaD
Nateglinide—CYP2C9—Metabolism—ABCA1—atherosclerosis	2.11e-06	4.65e-05	CbGpPWpGaD
Nateglinide—CYP3A4—Metabolism—PLA2G1B—atherosclerosis	2.08e-06	4.58e-05	CbGpPWpGaD
Nateglinide—CYP3A5—Metabolism—PPARA—atherosclerosis	2.08e-06	4.57e-05	CbGpPWpGaD
Nateglinide—ALB—Hemostasis—TGFB1—atherosclerosis	2.07e-06	4.56e-05	CbGpPWpGaD
Nateglinide—PTGS1—Metabolism—ALB—atherosclerosis	2.07e-06	4.56e-05	CbGpPWpGaD
Nateglinide—ALB—Metabolism—GSTM1—atherosclerosis	2.06e-06	4.54e-05	CbGpPWpGaD
Nateglinide—CYP3A7—Metabolism—NOS3—atherosclerosis	2.04e-06	4.5e-05	CbGpPWpGaD
Nateglinide—ALB—Metabolism—LPL—atherosclerosis	2.03e-06	4.46e-05	CbGpPWpGaD
Nateglinide—CYP3A5—Metabolism—AGT—atherosclerosis	2.01e-06	4.43e-05	CbGpPWpGaD
Nateglinide—CYP3A4—Metabolism—ALOX5—atherosclerosis	2.01e-06	4.42e-05	CbGpPWpGaD
Nateglinide—PTGS1—Metabolism—NOS3—atherosclerosis	1.98e-06	4.36e-05	CbGpPWpGaD
Nateglinide—ALB—Metabolism—GPX1—atherosclerosis	1.98e-06	4.35e-05	CbGpPWpGaD
Nateglinide—CYP3A5—Metabolism—APOE—atherosclerosis	1.97e-06	4.34e-05	CbGpPWpGaD
Nateglinide—CYP3A5—Metabolism—CAV1—atherosclerosis	1.95e-06	4.3e-05	CbGpPWpGaD
Nateglinide—CYP3A5—Metabolism—APOA1—atherosclerosis	1.95e-06	4.29e-05	CbGpPWpGaD
Nateglinide—ALB—Metabolism—CD36—atherosclerosis	1.92e-06	4.23e-05	CbGpPWpGaD
Nateglinide—CYP3A7—Metabolism—PTGS2—atherosclerosis	1.87e-06	4.11e-05	CbGpPWpGaD
Nateglinide—CYP2D6—Metabolism—HMOX1—atherosclerosis	1.83e-06	4.02e-05	CbGpPWpGaD
Nateglinide—ALB—Metabolism—MTHFR—atherosclerosis	1.82e-06	4.01e-05	CbGpPWpGaD
Nateglinide—ABCC8—Metabolism—AKT1—atherosclerosis	1.81e-06	3.99e-05	CbGpPWpGaD
Nateglinide—CYP2C9—Metabolism—HMOX1—atherosclerosis	1.81e-06	3.99e-05	CbGpPWpGaD
Nateglinide—PTGS1—Metabolism—PTGS2—atherosclerosis	1.81e-06	3.99e-05	CbGpPWpGaD
Nateglinide—CYP3A4—Metabolism—NAMPT—atherosclerosis	1.8e-06	3.97e-05	CbGpPWpGaD
Nateglinide—CYP3A4—Metabolism—LIPC—atherosclerosis	1.79e-06	3.94e-05	CbGpPWpGaD
Nateglinide—ALB—Metabolism—PPARA—atherosclerosis	1.79e-06	3.94e-05	CbGpPWpGaD
Nateglinide—CYP3A4—Metabolism—APOC3—atherosclerosis	1.78e-06	3.92e-05	CbGpPWpGaD
Nateglinide—CYP3A5—Metabolism—PIK3CG—atherosclerosis	1.78e-06	3.91e-05	CbGpPWpGaD
Nateglinide—CYP3A4—Metabolism—LDLR—atherosclerosis	1.77e-06	3.89e-05	CbGpPWpGaD
Nateglinide—KCNJ11—Metabolism—AKT1—atherosclerosis	1.76e-06	3.87e-05	CbGpPWpGaD
Nateglinide—CYP2D6—Metabolism—APOB—atherosclerosis	1.75e-06	3.85e-05	CbGpPWpGaD
Nateglinide—CYP2C9—Metabolism—APOB—atherosclerosis	1.74e-06	3.82e-05	CbGpPWpGaD
Nateglinide—SLC16A1—Metabolism—AKT1—atherosclerosis	1.73e-06	3.81e-05	CbGpPWpGaD
Nateglinide—ALB—Metabolism—AGT—atherosclerosis	1.73e-06	3.81e-05	CbGpPWpGaD
Nateglinide—CYP3A4—Metabolism—CETP—atherosclerosis	1.73e-06	3.8e-05	CbGpPWpGaD
Nateglinide—CYP3A5—Metabolism—PPARG—atherosclerosis	1.72e-06	3.78e-05	CbGpPWpGaD
Nateglinide—CYP2D6—Metabolism—GSTM1—atherosclerosis	1.7e-06	3.75e-05	CbGpPWpGaD
Nateglinide—ALB—Metabolism—APOE—atherosclerosis	1.7e-06	3.74e-05	CbGpPWpGaD
Nateglinide—CYP2C9—Metabolism—GSTM1—atherosclerosis	1.69e-06	3.72e-05	CbGpPWpGaD
Nateglinide—CYP3A5—Metabolism—INS—atherosclerosis	1.68e-06	3.71e-05	CbGpPWpGaD
Nateglinide—ALB—Metabolism—CAV1—atherosclerosis	1.68e-06	3.7e-05	CbGpPWpGaD
Nateglinide—ALB—Metabolism—APOA1—atherosclerosis	1.68e-06	3.69e-05	CbGpPWpGaD
Nateglinide—CYP2D6—Metabolism—LPL—atherosclerosis	1.67e-06	3.68e-05	CbGpPWpGaD
Nateglinide—PPARG—Gene Expression—AKT1—atherosclerosis	1.67e-06	3.68e-05	CbGpPWpGaD
Nateglinide—CYP2C9—Metabolism—LPL—atherosclerosis	1.66e-06	3.65e-05	CbGpPWpGaD
Nateglinide—CYP3A4—Metabolism—SCARB1—atherosclerosis	1.66e-06	3.64e-05	CbGpPWpGaD
Nateglinide—CYP2D6—Metabolism—GPX1—atherosclerosis	1.63e-06	3.59e-05	CbGpPWpGaD
Nateglinide—CYP2C9—Metabolism—GPX1—atherosclerosis	1.62e-06	3.56e-05	CbGpPWpGaD
Nateglinide—CYP2D6—Metabolism—CD36—atherosclerosis	1.59e-06	3.5e-05	CbGpPWpGaD
Nateglinide—CYP2C9—Metabolism—CD36—atherosclerosis	1.58e-06	3.47e-05	CbGpPWpGaD
Nateglinide—CYP3A4—Metabolism—HMGCR—atherosclerosis	1.56e-06	3.44e-05	CbGpPWpGaD
Nateglinide—CYP3A5—Metabolism—ALB—atherosclerosis	1.54e-06	3.4e-05	CbGpPWpGaD
Nateglinide—ALB—Metabolism—PIK3CG—atherosclerosis	1.53e-06	3.37e-05	CbGpPWpGaD
Nateglinide—CYP2D6—Metabolism—MTHFR—atherosclerosis	1.51e-06	3.31e-05	CbGpPWpGaD
Nateglinide—CYP2C9—Metabolism—MTHFR—atherosclerosis	1.49e-06	3.28e-05	CbGpPWpGaD
Nateglinide—ALB—Metabolism—PPARG—atherosclerosis	1.48e-06	3.25e-05	CbGpPWpGaD
Nateglinide—CYP2D6—Metabolism—PPARA—atherosclerosis	1.48e-06	3.25e-05	CbGpPWpGaD
Nateglinide—CYP3A5—Metabolism—NOS3—atherosclerosis	1.48e-06	3.25e-05	CbGpPWpGaD
Nateglinide—CYP2C9—Metabolism—PPARA—atherosclerosis	1.46e-06	3.22e-05	CbGpPWpGaD
Nateglinide—ALB—Metabolism—INS—atherosclerosis	1.45e-06	3.19e-05	CbGpPWpGaD
Nateglinide—ALB—Hemostasis—AKT1—atherosclerosis	1.44e-06	3.17e-05	CbGpPWpGaD
Nateglinide—CYP2D6—Metabolism—AGT—atherosclerosis	1.43e-06	3.15e-05	CbGpPWpGaD
Nateglinide—CYP2C9—Metabolism—AGT—atherosclerosis	1.42e-06	3.12e-05	CbGpPWpGaD
Nateglinide—CYP2D6—Metabolism—APOE—atherosclerosis	1.4e-06	3.08e-05	CbGpPWpGaD
Nateglinide—CYP3A4—Metabolism—ABCA1—atherosclerosis	1.39e-06	3.07e-05	CbGpPWpGaD
Nateglinide—CYP2C9—Metabolism—APOE—atherosclerosis	1.39e-06	3.06e-05	CbGpPWpGaD
Nateglinide—CYP2D6—Metabolism—CAV1—atherosclerosis	1.39e-06	3.06e-05	CbGpPWpGaD
Nateglinide—CYP2D6—Metabolism—APOA1—atherosclerosis	1.39e-06	3.05e-05	CbGpPWpGaD
Nateglinide—CYP2C9—Metabolism—CAV1—atherosclerosis	1.38e-06	3.03e-05	CbGpPWpGaD
Nateglinide—CYP2C9—Metabolism—APOA1—atherosclerosis	1.37e-06	3.02e-05	CbGpPWpGaD
Nateglinide—CYP3A5—Metabolism—PTGS2—atherosclerosis	1.35e-06	2.97e-05	CbGpPWpGaD
Nateglinide—PPARG—Metabolism—AKT1—atherosclerosis	1.3e-06	2.86e-05	CbGpPWpGaD
Nateglinide—ALB—Metabolism—NOS3—atherosclerosis	1.27e-06	2.8e-05	CbGpPWpGaD
Nateglinide—CYP2D6—Metabolism—PIK3CG—atherosclerosis	1.27e-06	2.78e-05	CbGpPWpGaD
Nateglinide—CYP2C9—Metabolism—PIK3CG—atherosclerosis	1.25e-06	2.76e-05	CbGpPWpGaD
Nateglinide—CYP2D6—Metabolism—PPARG—atherosclerosis	1.22e-06	2.69e-05	CbGpPWpGaD
Nateglinide—CYP2C9—Metabolism—PPARG—atherosclerosis	1.21e-06	2.66e-05	CbGpPWpGaD
Nateglinide—CYP2D6—Metabolism—INS—atherosclerosis	1.2e-06	2.63e-05	CbGpPWpGaD
Nateglinide—CYP3A4—Metabolism—HMOX1—atherosclerosis	1.2e-06	2.63e-05	CbGpPWpGaD
Nateglinide—CYP2C9—Metabolism—INS—atherosclerosis	1.19e-06	2.61e-05	CbGpPWpGaD
Nateglinide—ALB—Metabolism—PTGS2—atherosclerosis	1.16e-06	2.56e-05	CbGpPWpGaD
Nateglinide—CYP3A4—Metabolism—APOB—atherosclerosis	1.15e-06	2.52e-05	CbGpPWpGaD
Nateglinide—UGT1A9—Metabolism—AKT1—atherosclerosis	1.12e-06	2.46e-05	CbGpPWpGaD
Nateglinide—CYP3A4—Metabolism—GSTM1—atherosclerosis	1.11e-06	2.45e-05	CbGpPWpGaD
Nateglinide—CYP2D6—Metabolism—ALB—atherosclerosis	1.1e-06	2.42e-05	CbGpPWpGaD
Nateglinide—CYP3A4—Metabolism—LPL—atherosclerosis	1.09e-06	2.41e-05	CbGpPWpGaD
Nateglinide—CYP2C9—Metabolism—ALB—atherosclerosis	1.09e-06	2.39e-05	CbGpPWpGaD
Nateglinide—CYP3A4—Metabolism—GPX1—atherosclerosis	1.07e-06	2.35e-05	CbGpPWpGaD
Nateglinide—CYP2D6—Metabolism—NOS3—atherosclerosis	1.05e-06	2.31e-05	CbGpPWpGaD
Nateglinide—CYP2C9—Metabolism—NOS3—atherosclerosis	1.04e-06	2.29e-05	CbGpPWpGaD
Nateglinide—CYP3A4—Metabolism—CD36—atherosclerosis	1.04e-06	2.29e-05	CbGpPWpGaD
Nateglinide—CYP3A4—Metabolism—MTHFR—atherosclerosis	9.84e-07	2.17e-05	CbGpPWpGaD
Nateglinide—CYP3A4—Metabolism—PPARA—atherosclerosis	9.66e-07	2.13e-05	CbGpPWpGaD
Nateglinide—CYP2D6—Metabolism—PTGS2—atherosclerosis	9.61e-07	2.11e-05	CbGpPWpGaD
Nateglinide—CYP2C9—Metabolism—PTGS2—atherosclerosis	9.52e-07	2.1e-05	CbGpPWpGaD
Nateglinide—CYP3A7—Metabolism—AKT1—atherosclerosis	9.39e-07	2.07e-05	CbGpPWpGaD
Nateglinide—CYP3A4—Metabolism—AGT—atherosclerosis	9.35e-07	2.06e-05	CbGpPWpGaD
Nateglinide—CYP3A4—Metabolism—APOE—atherosclerosis	9.17e-07	2.02e-05	CbGpPWpGaD
Nateglinide—PTGS1—Metabolism—AKT1—atherosclerosis	9.1e-07	2e-05	CbGpPWpGaD
Nateglinide—CYP3A4—Metabolism—CAV1—atherosclerosis	9.08e-07	2e-05	CbGpPWpGaD
Nateglinide—CYP3A4—Metabolism—APOA1—atherosclerosis	9.06e-07	1.99e-05	CbGpPWpGaD
Nateglinide—CYP3A4—Metabolism—PIK3CG—atherosclerosis	8.27e-07	1.82e-05	CbGpPWpGaD
Nateglinide—CYP3A4—Metabolism—PPARG—atherosclerosis	7.98e-07	1.76e-05	CbGpPWpGaD
Nateglinide—CYP3A4—Metabolism—INS—atherosclerosis	7.83e-07	1.72e-05	CbGpPWpGaD
Nateglinide—CYP3A4—Metabolism—ALB—atherosclerosis	7.18e-07	1.58e-05	CbGpPWpGaD
Nateglinide—CYP3A4—Metabolism—NOS3—atherosclerosis	6.87e-07	1.51e-05	CbGpPWpGaD
Nateglinide—CYP3A5—Metabolism—AKT1—atherosclerosis	6.79e-07	1.49e-05	CbGpPWpGaD
Nateglinide—CYP3A4—Metabolism—PTGS2—atherosclerosis	6.28e-07	1.38e-05	CbGpPWpGaD
Nateglinide—ALB—Metabolism—AKT1—atherosclerosis	5.85e-07	1.29e-05	CbGpPWpGaD
Nateglinide—CYP2D6—Metabolism—AKT1—atherosclerosis	4.83e-07	1.06e-05	CbGpPWpGaD
Nateglinide—CYP2C9—Metabolism—AKT1—atherosclerosis	4.79e-07	1.05e-05	CbGpPWpGaD
Nateglinide—CYP3A4—Metabolism—AKT1—atherosclerosis	3.16e-07	6.94e-06	CbGpPWpGaD
